Peter O'Donnell is a freelance journalist who specializes in European health affairs and is based in Brussels, Belgium.

Articles

Upcoming study reveals challenges faced by Europe over the pricing of pharmaceuticals.

Can Europe Solve its Own Drug Pricing Dilemmas?

Pamela D. Garzone, Chief Medical Officer at Calibr, shares her perspectives on how investor decisions are shifting dramatically into biopharmaceuticals.

Where Are Clinical Trial Investments Going?

Vaccine manufacturers anticipate significant boosts in output in the coming weeks.

COVID-19 Vaccine Makers Overcome Challenges to Ramp Up Production

The latest initiative against COVID, the European Health Emergency Preparedness and Response Authority, is taking shape with intentions of revealing the vulnerabilities in global supply chains and more.

Europe's Leaders Still Discussing How to Respond to the COVID Pandemic

FDA issues a sharp warning letter rebuking AcelRx Pharmaceuticals for its ”glib and simplistic” messaging on painkiller Dsuvia.

FDA Blasts Misleading Opioid Promotion

After three years, member states of the EU have yet to make any real progress on legislation that would coordinate their clinical assessments more closely.

HTA—Easier to Reach Global Consensus Than an Agreement in Europe

Jane Myles, Director of Decentralized Trials at Covance by LabCorp, and former Head, Operational Intelligence and Innovation at Roche, discusses her journey as a clinical trial participant.

When Clinical Trial Professionals Participate as Subjects

Despite challenges and disruptions posed by the coronavirus pandemic this past year, FDA annual reports on drug regulatory programs and policies confirm successful efforts for meeting review time frames and updating policies and programs.

FDA Documents Recent Achievements, Maps Plans for Continued Progress

Jessica Lee, SVP Clinical Operations and Global Integration at Inovio Pharmaceuticals discusses her perspective on the emergence of novel COVID variants and how they could impact results for sponsors currently running COVID-19 studies

Running a COVID Vaccine Trial

R&D on medical treatments lags notable success with vaccines.

Blogs